News
A study led by Tim Greenamyre, MD, PhD, reported in Science Translational Medicine, suggests that experimental drugs that target the gene LRRK2 may be effective for common forms of Parkinson's. Learn More
TK Kozai, PhD, and neurologist Franca Cambi, MD, PhD, will investigate the role of oligodendrocytes and oligodendrocyte progenitor cells in neural tissue response to chronic brain implants. Learn More
Anna Marsland, Peter Gianaros and Tamer Ibrahim will use enhanced MRI to compare current brain health in middle-aged volunteers with old medical records about inflammation and heart health. Learn More
Carey Balaban, PhD, and his colleagues examined Havana embassy personnel, and find that a directed energy source could have damaged the sensitive utricle and saccule of the ear. Learn More
Peter Strick, PhD, says some of his recent work can be described in one sentence: "Mountcastle was right!" Learn More
Only 13 percent of eligible patients get DBS surgery for their intractable and debilitating Parkinson's symptoms. Neurosurgeon Mark Richardson, MD, PhD, would like that to change. Learn More
The Brain Institute's scientific director, Peter L. Strick, PhD, will be honored for his research using transneuronal transport of viruses to investigate brain networks. Learn More
Bioengineer Tamer Ibrahim, PhD, and colleagues plan to use the technology developed in his lab to investigate small-vessel disease in older adults with depression. Learn More
An age younger than 16, a history of migraines and being female are some of the risk factors that can extend recovery time after a sports-related head injury. Learn More
Marlene Cohen, PhD, and colleagues study what goes on at the neural level when the brain practices detecting differences in visual stimuli, a process called perceptual learning. Learn More
Neeraj Gandhi, PhD, will examine how the eye and brain compensate for lag times inherent in making sense of images in a world that doesn't stay still. Learn More
The mechanical engineer aims to create a wearable, ultrasound-based exoskeleton for the ankle, which can be used for rehabilitation after injury. Learn More
Jeffrey Yao, PhD, was recognized internationally for groundbreaking research on the biochemical aspects of disease processes in mental illness and neurological disorders. Learn More
The Aetna Foundation has provided a $1M grant for a two-year project in Pitt's Public Health Dynamics Laboratory. The lab will run computer models to evaluate how to focus resources. Learn More
"The data was there," said committee chair Rajesh Narendran, MD. If the FDA follows the panel's recommendation, lofexidine would become the first non-opioid drug approved to treat opioid withdrawal. Learn More
An FDA advisory committee headed by psychiatrist Rajesh Narendran, MD, meets today to consider recommending approval of the use of lofexidine, an alpha-2 adrenergic agonist similar to clonidine Learn More
The two-year project will investigate links between environmental and known genetic triggers of Parkinson's, such as LRRK2. Learn More
Meta-analysis of available data suggests that type and duration of physical activity doesn't matter much, though best results came from from a combination of cardiovascular and strength training. Learn More
Studies by Zachary Freyberg, MD, PhD, suggest that neurons can multitask and release two neurotransmitters -- such as dopamine and glutamate -- at once. Learn More
Letters of intent to apply for three-year collaborative awards are due April 3. The LOI due date for five-year awards for early-career scientists is April 17. Learn More